美国司法部宣布，Semler Scientific, Inc.和Bard Peripheral Vascular, Inc.将支付近3700万美元，以解决与Flochec和Quantaflo医疗设备相关的《虚假索赔法》指控。这一和解协议旨在解决两家公司在相关医疗设备销售和报销过程中涉嫌的不当行为。
美国司法部宣布，Semler Scientific, Inc.和Bard Peripheral Vascular, Inc.将支付近3700万美元，以解决与Flochec和Quantaflo医疗设备相关的《虚假索赔法》指控。这一和解协议旨在解决两家公司在相关医疗设备销售和报销过程中涉嫌的不当行为。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.